JP2015057052A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015057052A5 JP2015057052A5 JP2014184006A JP2014184006A JP2015057052A5 JP 2015057052 A5 JP2015057052 A5 JP 2015057052A5 JP 2014184006 A JP2014184006 A JP 2014184006A JP 2014184006 A JP2014184006 A JP 2014184006A JP 2015057052 A5 JP2015057052 A5 JP 2015057052A5
- Authority
- JP
- Japan
- Prior art keywords
- adenovirus
- protein
- recombinant adenovirus
- seq
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 241000701161 unidentified adenovirus Species 0.000 claims 55
- 239000012634 fragment Substances 0.000 claims 15
- 210000000234 capsid Anatomy 0.000 claims 13
- 101710094396 Hexon protein Proteins 0.000 claims 12
- 101710145505 Fiber protein Proteins 0.000 claims 10
- 101710173835 Penton protein Proteins 0.000 claims 9
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 5
- 108700019146 Transgenes Proteins 0.000 claims 5
- 125000000539 amino acid group Chemical group 0.000 claims 5
- 150000007523 nucleic acids Chemical group 0.000 claims 5
- 108090000565 Capsid Proteins Proteins 0.000 claims 4
- 241000282693 Cercopithecidae Species 0.000 claims 4
- 102100023321 Ceruloplasmin Human genes 0.000 claims 4
- 101000833492 Homo sapiens Jouberin Proteins 0.000 claims 4
- 101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 claims 4
- 102100024407 Jouberin Human genes 0.000 claims 4
- 101710087110 ORF6 protein Proteins 0.000 claims 4
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 claims 4
- 101710130262 Probable Vpr-like protein Proteins 0.000 claims 4
- 101710110895 Uncharacterized 7.3 kDa protein in cox-rep intergenic region Proteins 0.000 claims 4
- 101710095001 Uncharacterized protein in nifU 5'region Proteins 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 230000010076 replication Effects 0.000 claims 4
- 101000768957 Acholeplasma phage L2 Uncharacterized 37.2 kDa protein Proteins 0.000 claims 3
- 101000823746 Acidianus ambivalens Uncharacterized 17.7 kDa protein in bps2 3'region Proteins 0.000 claims 3
- 101000916369 Acidianus ambivalens Uncharacterized protein in sor 5'region Proteins 0.000 claims 3
- 101000769342 Acinetobacter guillouiae Uncharacterized protein in rpoN-murA intergenic region Proteins 0.000 claims 3
- 101000823696 Actinobacillus pleuropneumoniae Uncharacterized glycosyltransferase in aroQ 3'region Proteins 0.000 claims 3
- 101000786513 Agrobacterium tumefaciens (strain 15955) Uncharacterized protein outside the virF region Proteins 0.000 claims 3
- 101000618005 Alkalihalobacillus pseudofirmus (strain ATCC BAA-2126 / JCM 17055 / OF4) Uncharacterized protein BpOF4_00885 Proteins 0.000 claims 3
- 102100020724 Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Human genes 0.000 claims 3
- 101000967489 Azorhizobium caulinodans (strain ATCC 43989 / DSM 5975 / JCM 20966 / LMG 6465 / NBRC 14845 / NCIMB 13405 / ORS 571) Uncharacterized protein AZC_3924 Proteins 0.000 claims 3
- 101000823761 Bacillus licheniformis Uncharacterized 9.4 kDa protein in flaL 3'region Proteins 0.000 claims 3
- 101000819719 Bacillus methanolicus Uncharacterized N-acetyltransferase in lysA 3'region Proteins 0.000 claims 3
- 101000789586 Bacillus subtilis (strain 168) UPF0702 transmembrane protein YkjA Proteins 0.000 claims 3
- 101000792624 Bacillus subtilis (strain 168) Uncharacterized protein YbxH Proteins 0.000 claims 3
- 101000790792 Bacillus subtilis (strain 168) Uncharacterized protein YckC Proteins 0.000 claims 3
- 101000819705 Bacillus subtilis (strain 168) Uncharacterized protein YlxR Proteins 0.000 claims 3
- 101000948218 Bacillus subtilis (strain 168) Uncharacterized protein YtxJ Proteins 0.000 claims 3
- 101000718627 Bacillus thuringiensis subsp. kurstaki Putative RNA polymerase sigma-G factor Proteins 0.000 claims 3
- 101000641200 Bombyx mori densovirus Putative non-structural protein Proteins 0.000 claims 3
- 101000947633 Claviceps purpurea Uncharacterized 13.8 kDa protein Proteins 0.000 claims 3
- 101000948901 Enterobacteria phage T4 Uncharacterized 16.0 kDa protein in segB-ipI intergenic region Proteins 0.000 claims 3
- 101000805958 Equine herpesvirus 4 (strain 1942) Virion protein US10 homolog Proteins 0.000 claims 3
- 101000790442 Escherichia coli Insertion element IS2 uncharacterized 11.1 kDa protein Proteins 0.000 claims 3
- 101000788354 Escherichia phage P2 Uncharacterized 8.2 kDa protein in gpA 5'region Proteins 0.000 claims 3
- 101000770304 Frankia alni UPF0460 protein in nifX-nifW intergenic region Proteins 0.000 claims 3
- 101000797344 Geobacillus stearothermophilus Putative tRNA (cytidine(34)-2'-O)-methyltransferase Proteins 0.000 claims 3
- 101000748410 Geobacillus stearothermophilus Uncharacterized protein in fumA 3'region Proteins 0.000 claims 3
- 101000772675 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) UPF0438 protein HI_0847 Proteins 0.000 claims 3
- 101000631019 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Uncharacterized protein HI_0350 Proteins 0.000 claims 3
- 101000768938 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.9 kDa protein in int-C1 intergenic region Proteins 0.000 claims 3
- 101000785414 Homo sapiens Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Proteins 0.000 claims 3
- 101000782488 Junonia coenia densovirus (isolate pBRJ/1990) Putative non-structural protein NS2 Proteins 0.000 claims 3
- 101000811523 Klebsiella pneumoniae Uncharacterized 55.8 kDa protein in cps region Proteins 0.000 claims 3
- 101000818409 Lactococcus lactis subsp. lactis Uncharacterized HTH-type transcriptional regulator in lacX 3'region Proteins 0.000 claims 3
- 101000878851 Leptolyngbya boryana Putative Fe(2+) transport protein A Proteins 0.000 claims 3
- 101000758828 Methanosarcina barkeri (strain Fusaro / DSM 804) Uncharacterized protein Mbar_A1602 Proteins 0.000 claims 3
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 claims 3
- 101001122401 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF3 Proteins 0.000 claims 3
- 101001055788 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) Pentapeptide repeat protein MfpA Proteins 0.000 claims 3
- 101000740670 Orgyia pseudotsugata multicapsid polyhedrosis virus Protein C42 Proteins 0.000 claims 3
- 101000769182 Photorhabdus luminescens Uncharacterized protein in pnp 3'region Proteins 0.000 claims 3
- 101000961392 Pseudescherichia vulneris Uncharacterized 29.9 kDa protein in crtE 3'region Proteins 0.000 claims 3
- 101000731030 Pseudomonas oleovorans Poly(3-hydroxyalkanoate) polymerase 2 Proteins 0.000 claims 3
- 101001065485 Pseudomonas putida Probable fatty acid methyltransferase Proteins 0.000 claims 3
- 101000711023 Rhizobium leguminosarum bv. trifolii Uncharacterized protein in tfuA 3'region Proteins 0.000 claims 3
- 101000948156 Rhodococcus erythropolis Uncharacterized 47.3 kDa protein in thcA 5'region Proteins 0.000 claims 3
- 101000917565 Rhodococcus fascians Uncharacterized 33.6 kDa protein in fasciation locus Proteins 0.000 claims 3
- 101000790284 Saimiriine herpesvirus 2 (strain 488) Uncharacterized 9.5 kDa protein in DHFR 3'region Proteins 0.000 claims 3
- 101000936719 Streptococcus gordonii Accessory Sec system protein Asp3 Proteins 0.000 claims 3
- 101000788499 Streptomyces coelicolor Uncharacterized oxidoreductase in mprA 5'region Proteins 0.000 claims 3
- 101001102841 Streptomyces griseus Purine nucleoside phosphorylase ORF3 Proteins 0.000 claims 3
- 101000708557 Streptomyces lincolnensis Uncharacterized 17.2 kDa protein in melC2-rnhH intergenic region Proteins 0.000 claims 3
- 101000649826 Thermotoga neapolitana Putative anti-sigma factor antagonist TM1081 homolog Proteins 0.000 claims 3
- 101000827562 Vibrio alginolyticus Uncharacterized protein in proC 3'region Proteins 0.000 claims 3
- 101000778915 Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) Uncharacterized membrane protein VP2115 Proteins 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- 210000004899 c-terminal region Anatomy 0.000 claims 3
- 230000000295 complement effect Effects 0.000 claims 3
- 239000012678 infectious agent Substances 0.000 claims 3
- 101000621943 Acholeplasma phage L2 Probable integrase/recombinase Proteins 0.000 claims 2
- 101000618348 Allochromatium vinosum (strain ATCC 17899 / DSM 180 / NBRC 103801 / NCIMB 10441 / D) Uncharacterized protein Alvin_0065 Proteins 0.000 claims 2
- 101000781117 Autographa californica nuclear polyhedrosis virus Uncharacterized 12.4 kDa protein in CTL-LEF2 intergenic region Proteins 0.000 claims 2
- 101000708323 Azospirillum brasilense Uncharacterized 28.8 kDa protein in nifR3-like 5'region Proteins 0.000 claims 2
- 101000770311 Azotobacter chroococcum mcd 1 Uncharacterized 19.8 kDa protein in nifW 5'region Proteins 0.000 claims 2
- 101000748761 Bacillus subtilis (strain 168) Uncharacterized MFS-type transporter YcxA Proteins 0.000 claims 2
- 101000765620 Bacillus subtilis (strain 168) Uncharacterized protein YlxP Proteins 0.000 claims 2
- 101000916134 Bacillus subtilis (strain 168) Uncharacterized protein YqxJ Proteins 0.000 claims 2
- 101000754349 Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251) UPF0065 protein BP0148 Proteins 0.000 claims 2
- 101000827633 Caldicellulosiruptor sp. (strain Rt8B.4) Uncharacterized 23.9 kDa protein in xynA 3'region Proteins 0.000 claims 2
- 101000947628 Claviceps purpurea Uncharacterized 11.8 kDa protein Proteins 0.000 claims 2
- 101000686796 Clostridium perfringens Replication protein Proteins 0.000 claims 2
- 102100031725 Cortactin-binding protein 2 Human genes 0.000 claims 2
- 101150029662 E1 gene Proteins 0.000 claims 2
- 101000788129 Escherichia coli Uncharacterized protein in sul1 3'region Proteins 0.000 claims 2
- 101000788370 Escherichia phage P2 Uncharacterized 12.9 kDa protein in GpA 3'region Proteins 0.000 claims 2
- 101000787096 Geobacillus stearothermophilus Uncharacterized protein in gldA 3'region Proteins 0.000 claims 2
- 101000976889 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 19.2 kDa protein in cox-rep intergenic region Proteins 0.000 claims 2
- 241001135569 Human adenovirus 5 Species 0.000 claims 2
- 241000193096 Human adenovirus B3 Species 0.000 claims 2
- 101000908757 Human adenovirus C serotype 2 Early 4 ORF4 protein Proteins 0.000 claims 2
- 101000827627 Klebsiella pneumoniae Putative low molecular weight protein-tyrosine-phosphatase Proteins 0.000 claims 2
- 101001130841 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF5 Proteins 0.000 claims 2
- 101710197985 Probable protein Rev Proteins 0.000 claims 2
- 102100040307 Protein FAM3B Human genes 0.000 claims 2
- 101000974028 Rhizobium leguminosarum bv. viciae (strain 3841) Putative cystathionine beta-lyase Proteins 0.000 claims 2
- 101000756519 Rhodobacter capsulatus (strain ATCC BAA-309 / NBRC 16581 / SB1003) Uncharacterized protein RCAP_rcc00048 Proteins 0.000 claims 2
- 101000948219 Rhodococcus erythropolis Uncharacterized 11.5 kDa protein in thcD 3'region Proteins 0.000 claims 2
- 101000936711 Streptococcus gordonii Accessory secretory protein Asp4 Proteins 0.000 claims 2
- 101000929863 Streptomyces cinnamonensis Monensin polyketide synthase putative ketoacyl reductase Proteins 0.000 claims 2
- 101000788468 Streptomyces coelicolor Uncharacterized protein in mprR 3'region Proteins 0.000 claims 2
- 101000845085 Streptomyces violaceoruber Granaticin polyketide synthase putative ketoacyl reductase 1 Proteins 0.000 claims 2
- 101000711771 Thiocystis violacea Uncharacterized 76.5 kDa protein in phbC 3'region Proteins 0.000 claims 2
- 101710198378 Uncharacterized 10.8 kDa protein in cox-rep intergenic region Proteins 0.000 claims 2
- 101710134973 Uncharacterized 9.7 kDa protein in cox-rep intergenic region Proteins 0.000 claims 2
- 101000711318 Vibrio alginolyticus Uncharacterized 11.6 kDa protein in scrR 3'region Proteins 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 239000000835 fiber Substances 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33195101P | 2001-11-21 | 2001-11-21 | |
| US60/331,951 | 2001-11-21 | ||
| US36679802P | 2002-03-22 | 2002-03-22 | |
| US60/366,798 | 2002-03-22 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013167091A Division JP2013252144A (ja) | 2001-11-21 | 2013-08-09 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016220443A Division JP2017070292A (ja) | 2001-11-21 | 2016-11-11 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
| JP2016220444A Division JP2017035111A (ja) | 2001-11-21 | 2016-11-11 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015057052A JP2015057052A (ja) | 2015-03-26 |
| JP2015057052A5 true JP2015057052A5 (https=) | 2015-05-07 |
Family
ID=26987985
Family Applications (9)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003547559A Withdrawn JP2005511035A (ja) | 2001-11-21 | 2002-11-20 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
| JP2009018231A Expired - Fee Related JP5715749B2 (ja) | 2001-11-21 | 2009-01-29 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
| JP2010225018A Pending JP2011055835A (ja) | 2001-11-21 | 2010-10-04 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
| JP2013167091A Pending JP2013252144A (ja) | 2001-11-21 | 2013-08-09 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
| JP2014184006A Ceased JP2015057052A (ja) | 2001-11-21 | 2014-09-10 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
| JP2014184003A Withdrawn JP2015057051A (ja) | 2001-11-21 | 2014-09-10 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
| JP2016220444A Pending JP2017035111A (ja) | 2001-11-21 | 2016-11-11 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
| JP2016220440A Pending JP2017035110A (ja) | 2001-11-21 | 2016-11-11 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
| JP2016220443A Pending JP2017070292A (ja) | 2001-11-21 | 2016-11-11 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
Family Applications Before (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003547559A Withdrawn JP2005511035A (ja) | 2001-11-21 | 2002-11-20 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
| JP2009018231A Expired - Fee Related JP5715749B2 (ja) | 2001-11-21 | 2009-01-29 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
| JP2010225018A Pending JP2011055835A (ja) | 2001-11-21 | 2010-10-04 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
| JP2013167091A Pending JP2013252144A (ja) | 2001-11-21 | 2013-08-09 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014184003A Withdrawn JP2015057051A (ja) | 2001-11-21 | 2014-09-10 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
| JP2016220444A Pending JP2017035111A (ja) | 2001-11-21 | 2016-11-11 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
| JP2016220440A Pending JP2017035110A (ja) | 2001-11-21 | 2016-11-11 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
| JP2016220443A Pending JP2017070292A (ja) | 2001-11-21 | 2016-11-11 | サルアデノウイルス核酸およびアミノ酸配列、それを含むベクターおよび使用方法 |
Country Status (19)
| Country | Link |
|---|---|
| US (5) | US7247472B2 (https=) |
| EP (4) | EP1453543B1 (https=) |
| JP (9) | JP2005511035A (https=) |
| KR (1) | KR100987360B1 (https=) |
| CN (1) | CN1578678B (https=) |
| AU (1) | AU2002365366B2 (https=) |
| BR (1) | BR0214350A (https=) |
| CA (3) | CA2466431C (https=) |
| CO (1) | CO5590973A2 (https=) |
| HU (3) | HU230365B1 (https=) |
| IL (5) | IL161584A0 (https=) |
| MX (2) | MX351516B (https=) |
| NO (3) | NO332692B1 (https=) |
| NZ (3) | NZ550416A (https=) |
| PH (1) | PH12016500338A1 (https=) |
| PL (1) | PL209133B1 (https=) |
| SG (2) | SG165153A1 (https=) |
| WO (1) | WO2003046124A2 (https=) |
| ZA (1) | ZA200403117B (https=) |
Families Citing this family (119)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1409748B1 (en) | 2001-06-22 | 2011-10-26 | The Trustees of The University of Pennsylvania | Recombinant Adenoviruses comprising simian adenovirus proteins and uses thereof. |
| US20040136963A1 (en) * | 2001-06-22 | 2004-07-15 | The Trustees Of The University Of Pennsylvania | Simian adenovirus vectors and methods of use |
| AU2002365366B2 (en) * | 2001-11-21 | 2007-05-10 | The Trustees Of The University Of Pennsylvania | Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| AU2003285932A1 (en) | 2002-10-23 | 2004-05-13 | Glaxosmithkline Biologicals S.A. | Methods for vaccinating against malaria |
| US7291498B2 (en) | 2003-06-20 | 2007-11-06 | The Trustees Of The University Of Pennsylvania | Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| CA2528511C (en) * | 2003-06-20 | 2015-11-03 | The Trustees Of The University Of Pennsylvania | Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| DE602005017743D1 (de) * | 2004-01-23 | 2009-12-31 | Angeletti P Ist Richerche Bio | Impfstoffträger für schimpansen-adenovirus |
| CA2563500C (en) * | 2004-04-28 | 2016-06-28 | The Trustees Of The University Of Pennsylvania | Immunization regimen with e4-deleted adenovirus prime and e1-deleted adenovirus boost |
| ES2361000T3 (es) * | 2004-04-28 | 2011-06-13 | The Trustees Of The University Of Pennsylvania | Suministro secuencial de moléculas inmunogénicas mediante administraciones de un adenovirus y de un virus adeno-asociado. |
| EP1773303A2 (en) * | 2004-05-25 | 2007-04-18 | Chimeracore, Inc. | Self-assembling nanoparticle drug delivery system |
| GB0417494D0 (en) | 2004-08-05 | 2004-09-08 | Glaxosmithkline Biolog Sa | Vaccine |
| CN102220357B (zh) | 2004-11-16 | 2013-12-25 | 克鲁塞尔荷兰公司 | 包含重组病毒载体的多价疫苗 |
| EP1863520B1 (en) * | 2005-03-08 | 2014-12-31 | Aptose Biosciences Inc. | Use of interleukin 17e for the treatment of cancer |
| GB0513421D0 (en) | 2005-06-30 | 2005-08-03 | Glaxosmithkline Biolog Sa | Vaccines |
| CA2648581A1 (en) * | 2006-04-07 | 2008-09-12 | Chimeros, Inc. | Compositions and methods for treating b- cell malignancies |
| EP2012822B1 (en) * | 2006-04-28 | 2010-01-20 | The Trustees of the University of Pennsylvania | Modified adenovirus hexon protein and uses thereof |
| WO2008027394A2 (en) | 2006-08-28 | 2008-03-06 | The Wistar Institute Of Anatomy And Biology | Constructs for enhancing immune responses |
| PL2137210T3 (pl) | 2007-03-02 | 2017-06-30 | Glaxosmithkline Biologicals Sa | Nowy sposób i kompozycje |
| CA2683063A1 (en) * | 2007-04-09 | 2008-10-16 | Chimeros, Inc. | Self-assembling nanoparticle drug delivery system |
| AU2008331905B2 (en) * | 2007-11-28 | 2014-09-18 | The Trustees Of The University Of Pennsylvania | Simian subfamily B adenovirus SAdV-28 and uses thereof |
| CN101883858B (zh) * | 2007-11-28 | 2015-07-22 | 宾夕法尼亚大学托管会 | 猿猴亚家族E腺病毒SAdV-39、-25.2、-26、-30、-37和-38及其应用 |
| CN102131920B (zh) * | 2007-11-28 | 2013-11-06 | 宾夕法尼亚大学托管会 | 猿猴亚家族C腺病毒SAdV-40、-31和-34及其应用 |
| AU2014203073B2 (en) * | 2007-11-28 | 2016-07-07 | The Trustees Of The University Of Pennsylvania | Simian E adenovirus SAdV-30 |
| JP5661476B2 (ja) * | 2008-03-04 | 2015-01-28 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | サルアデノウイルスＳＡｄＶ−３６、−４２．１、−４２．２および−４４ならびにそれらの用途 |
| US9217155B2 (en) | 2008-05-28 | 2015-12-22 | University Of Massachusetts | Isolation of novel AAV'S and uses thereof |
| WO2010051367A1 (en) | 2008-10-31 | 2010-05-06 | The Trustees Of The University Of Pennsylvania | Simian adenoviruses sadv-43, -45,-48,-49, and -50 and uses thereof |
| WO2010085984A1 (en) * | 2009-02-02 | 2010-08-05 | Okairos Ag | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |
| PL2391638T3 (pl) * | 2009-02-02 | 2018-11-30 | Glaxosmithkline Biologicals Sa | Sekwencje nukleotydowe i aminokwasowe małpiego adenowirusa, zawierające je wektory i ich zastosowania |
| SG174877A1 (en) | 2009-03-17 | 2011-11-28 | Mdxhealth Sa | Improved detection of gene expression |
| WO2010120874A2 (en) | 2009-04-14 | 2010-10-21 | Chimeros, Inc. | Chimeric therapeutics, compositions, and methods for using same |
| US8734809B2 (en) | 2009-05-28 | 2014-05-27 | University Of Massachusetts | AAV's and uses thereof |
| CA2762203A1 (en) | 2009-05-29 | 2010-12-02 | Soumitra Roy | Simian adenovirus 41 and uses thereof |
| WO2011057254A2 (en) | 2009-11-09 | 2011-05-12 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Simian adenoviral vector-based vaccines |
| KR20120139672A (ko) | 2009-11-09 | 2012-12-27 | 젠벡, 인코포레이티드 | 원숭이 아데노바이러스 벡터의 증식 방법 |
| EP2558481B1 (en) * | 2010-04-14 | 2017-12-20 | Mogam Biotechnology Research Institute | Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the same |
| EP3444346B1 (en) | 2010-04-23 | 2022-07-27 | University of Massachusetts | Aav-based treatment of cholesterol-related disorders |
| EP2561073B1 (en) | 2010-04-23 | 2016-08-24 | University of Massachusetts | Cns targeting aav vectors and methods of use thereof |
| US9546369B2 (en) | 2010-04-23 | 2017-01-17 | University Of Massachusetts | Multicistronic expression constructs |
| TR201802741T4 (tr) * | 2010-05-14 | 2018-03-21 | Univ Oregon Health & Science | Rekombinant hcmv ve rhcmv vektörleri ve bunların kullanımları. |
| WO2012021730A2 (en) | 2010-08-11 | 2012-02-16 | Genvec, Inc. | Respiratory syncytial virus (rsv) vaccine |
| US8771709B2 (en) | 2010-09-20 | 2014-07-08 | Crucell Holland B.V. | Therapeutic vaccination against active Tuberculosis |
| AU2011332025B2 (en) | 2010-11-23 | 2015-06-25 | The Trustees Of The University Of Pennsylvania | Subfamily E simian adenoviruses A1321, A1325, A1295, A1309 and A1322 and uses thereof |
| WO2012088608A1 (en) | 2010-12-27 | 2012-07-05 | Enobia Canada Limited Partnership | Compositions comprising natriuretic peptides and methods of use thereof |
| WO2012089231A1 (en) * | 2010-12-30 | 2012-07-05 | Okairòs Ag | Paramyxovirus vaccines |
| US9267112B2 (en) | 2011-05-10 | 2016-02-23 | The Regents Of The University Of California | Adenovirus isolated from Titi Monkeys |
| US10221218B2 (en) | 2011-05-10 | 2019-03-05 | The Regents Of The University Of California | Adenovirus isolated from titi monkeys |
| GB201108879D0 (en) | 2011-05-25 | 2011-07-06 | Isis Innovation | Vector |
| TWI623618B (zh) | 2011-07-12 | 2018-05-11 | 傳斯堅公司 | Ｈｂｖ聚合酶突變體 |
| WO2013036791A2 (en) * | 2011-09-09 | 2013-03-14 | Beth Israel Deaconess Medical Center, Inc. | Modified adenoviral vectors and methods of treatment using same |
| CA2847888A1 (en) | 2011-09-09 | 2013-03-14 | Biomed Realty, L.P. | Methods and compositions for controlling assembly of viral proteins |
| WO2013045668A2 (en) | 2011-09-29 | 2013-04-04 | Transgene Sa | Immunotherapy composition and regimen for treating hepatitis c virus infection |
| TW201318637A (zh) | 2011-09-29 | 2013-05-16 | Transgene Sa | 免疫療法組成物及用於治療ｃ型肝炎病毒感染之療程（一） |
| JP6757120B2 (ja) * | 2011-10-05 | 2020-09-16 | ジェンヴェック エルエルシー | アーフェンアデノウイルス（ゴリラ）又はアデノウイルスベクター、及び使用方法 |
| KR20140084201A (ko) | 2011-10-19 | 2014-07-04 | 알렉시온 파마 홀딩 | 알칼리성 포스파타제 및/또는 나트륨이뇨 펩티드를 포함하는 조성물 및 그의 사용 방법 |
| US9226936B2 (en) | 2011-10-28 | 2016-01-05 | The Wistar of Anatomy and Biology | Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells |
| US10238755B2 (en) | 2011-11-30 | 2019-03-26 | The Wistar Institute Of Anatomy And Biology | Methods and compositions for regulation of cell aging, carcinogenesis and reprogramming |
| SG11201407343XA (en) | 2012-05-18 | 2014-12-30 | Univ Pennsylvania | Subfamily e simian adenoviruses a1302, a1320, a1331 and a1337 and uses thereof |
| EP2892554B1 (en) | 2012-09-07 | 2020-08-26 | Emory University | Hiv immune stimulating compositions comprising recombinantly expressed pili on bacteria and methods related thereto |
| US9683268B2 (en) * | 2012-09-19 | 2017-06-20 | Beth Israel Deaconess | Viruses associated with immunodeficiency and enteropathy and methods using same |
| US10106781B2 (en) * | 2012-11-16 | 2018-10-23 | Beth Israel Deaconess Medical Center, Inc. | Recombinant adenoviruses and use thereof |
| JP2016505267A (ja) * | 2013-01-15 | 2016-02-25 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | アデノウイルスおよびその使用 |
| US9624510B2 (en) | 2013-03-01 | 2017-04-18 | The Wistar Institute | Adenoviral vectors comprising partial deletions of E3 |
| SG11201507393TA (en) | 2013-03-14 | 2015-10-29 | Salk Inst For Biological Studi | Oncolytic adenovirus compositions |
| US9402888B2 (en) | 2013-03-14 | 2016-08-02 | The Wistar Institute Of Anatomy And Biology | Methods and compositions for treating cancer |
| WO2015063647A1 (en) * | 2013-11-01 | 2015-05-07 | Pfizer Inc. | Vectors for expression of prostate-associated antigens |
| EP3151866B1 (en) | 2014-06-09 | 2023-03-08 | Voyager Therapeutics, Inc. | Chimeric capsids |
| KR102608590B1 (ko) | 2014-09-24 | 2023-12-01 | 솔크 인스티튜트 포 바이올로지칼 스터디즈 | 종양 살상 바이러스 및 이의 사용방법 |
| HRP20210705T1 (hr) | 2014-10-02 | 2021-07-23 | The Wistar Institute Of Anatomy And Biology | Postupci i pripravci za liječenje raka |
| US10941452B2 (en) | 2014-10-06 | 2021-03-09 | The Trustees Of The University Of Pennsylvania | Compositions and methods for isolation of circulating tumor cells (CTC) |
| CN107073051B (zh) | 2014-10-21 | 2021-08-24 | 马萨诸塞大学 | 重组aav变体及其用途 |
| RU2716991C2 (ru) | 2014-11-05 | 2020-03-17 | Вояджер Терапьютикс, Инк. | Полинуклеотиды aadc для лечения болезни паркинсона |
| WO2016077687A1 (en) | 2014-11-14 | 2016-05-19 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (als) |
| KR20230145206A (ko) | 2014-11-14 | 2023-10-17 | 보이저 테라퓨틱스, 인크. | 조절성 폴리뉴클레오티드 |
| US11697825B2 (en) | 2014-12-12 | 2023-07-11 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scAAV |
| EP4523756A3 (en) | 2015-02-13 | 2025-05-28 | Transgene | Immunotherapeutic vaccine and antibody combination therapy |
| WO2016131945A1 (en) | 2015-02-20 | 2016-08-25 | Transgene Sa | Combination product with autophagy modulator |
| BR112017026523A2 (pt) * | 2015-06-12 | 2018-08-14 | Glaxosmithkline Biologicals Sa | vetor recombinante, adenovírus recombinante, composição, uso de um vetor recombinante, de um adenovírus recombinante ou de uma composição, método para induzir uma resposta imune em um indivíduo, e, polinucleotídeo isolado. |
| EP3384035A4 (en) | 2015-12-02 | 2019-08-07 | Voyager Therapeutics, Inc. | ASSAYS FOR THE DETECTION OF AAV-NEUTRALIZING ANTIBODIES |
| US11208468B2 (en) | 2016-02-18 | 2021-12-28 | The Wistar Institute Of Anatomy And Biology | Methods and compositions for treating melanoma |
| WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| WO2017147269A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics |
| US11299751B2 (en) | 2016-04-29 | 2022-04-12 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| EP3448874A4 (en) | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| CA3023022A1 (en) | 2016-05-04 | 2017-11-09 | Transgene Sa | Combination therapy with cpg tlr9 ligand |
| KR102427379B1 (ko) | 2016-05-18 | 2022-08-02 | 보이저 테라퓨틱스, 인크. | 헌팅톤 질환을 치료하기 위한 조성물 및 방법 |
| KR20240056729A (ko) | 2016-05-18 | 2024-04-30 | 보이저 테라퓨틱스, 인크. | 조절성 폴리뉴클레오티드 |
| EP3490610A4 (en) * | 2016-08-01 | 2020-05-20 | The Wistar Institute Of Anatomy And Biology | Compositions and methods of replication deficient adenoviral vectors for vaccine applications |
| IL315358A (en) | 2016-08-18 | 2024-11-01 | Univ California | CRISPR-CAS genome engineering using a modular AAV delivery system |
| WO2018044933A1 (en) | 2016-08-30 | 2018-03-08 | The Regents Of The University Of California | Methods for biomedical targeting and delivery and devices and systems for practicing the same |
| WO2018069316A2 (en) | 2016-10-10 | 2018-04-19 | Transgene Sa | Immunotherapeutic product and mdsc modulator combination therapy |
| AU2017341849B2 (en) | 2016-10-13 | 2024-03-21 | University Of Massachusetts | AAV capsid designs |
| EP3532082A4 (en) | 2016-12-12 | 2020-08-26 | Salk Institute for Biological Studies | SYNTHETIC ADENOVIRUS TUMOR TARGETING AND THEIR USES |
| JP2020518258A (ja) | 2017-05-05 | 2020-06-25 | ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | 筋萎縮性側索硬化症（ａｌｓ）治療組成物および方法 |
| JP2020518259A (ja) | 2017-05-05 | 2020-06-25 | ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | ハンチントン病治療組成物および方法 |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| CA3070087A1 (en) | 2017-07-17 | 2019-01-24 | Voyager Therapeutics, Inc. | Trajectory array guide system |
| EP3808849A1 (en) | 2017-08-03 | 2021-04-21 | Voyager Therapeutics, Inc. | Compositions and methods for delivery of aav |
| AU2018338728B2 (en) | 2017-09-29 | 2025-01-02 | Centre National De La Recherche Scientifique (Cnrs) | Rescue of central and peripheral neurological phenotype of Friedreich's Ataxia by intravenous delivery |
| TW202413649A (zh) | 2017-10-16 | 2024-04-01 | 美商航海家醫療公司 | 肌萎縮性脊髓側索硬化症(als)之治療 |
| EP3697908A1 (en) | 2017-10-16 | 2020-08-26 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis (als) |
| US11773142B2 (en) | 2017-12-11 | 2023-10-03 | Beth Israel Deaconess Medical Center, Inc. | Recombinant adenoviruses and uses thereof |
| CN112292449A (zh) | 2018-04-09 | 2021-01-29 | 萨克生物研究学院 | 具有增强的复制特性的溶瘤腺病毒组合物 |
| KR20210019996A (ko) | 2018-05-15 | 2021-02-23 | 보이저 테라퓨틱스, 인크. | 파킨슨병의 치료를 위한 조성물 및 방법 |
| WO2019241486A1 (en) | 2018-06-13 | 2019-12-19 | Voyager Therapeutics, Inc. | Engineered 5' untranslated regions (5' utr) for aav production |
| EP3823981A4 (en) | 2018-07-17 | 2022-04-06 | Neuromyon Inc. | TREATMENT OF NEUROPATHY WITH DNA CONSTRUCTS EXPRESSING IGF-1 ISOFORMS |
| CN112770812A (zh) | 2018-07-24 | 2021-05-07 | 沃雅戈治疗公司 | 产生基因治疗制剂的系统和方法 |
| EP3856762A1 (en) | 2018-09-28 | 2021-08-04 | Voyager Therapeutics, Inc. | Frataxin expression constructs having engineered promoters and methods of use thereof |
| WO2020072849A1 (en) | 2018-10-04 | 2020-04-09 | Voyager Therapeutics, Inc. | Methods for measuring the titer and potency of viral vector particles |
| WO2020072844A1 (en) | 2018-10-05 | 2020-04-09 | Voyager Therapeutics, Inc. | Engineered nucleic acid constructs encoding aav production proteins |
| CN113166781A (zh) | 2018-10-15 | 2021-07-23 | 沃雅戈治疗公司 | 在杆状病毒/Sf9系统中大规模生产rAAV的表达载体 |
| WO2020160508A1 (en) | 2019-01-31 | 2020-08-06 | Oregon Health & Science University | Methods for using transcription-dependent directed evolution of aav capsids |
| CN114269363A (zh) * | 2019-04-17 | 2022-04-01 | 威斯达研究所 | 用于hiv疫苗应用的复制缺陷型腺病毒载体 |
| CN116322740A (zh) | 2020-07-13 | 2023-06-23 | 特兰斯吉恩股份有限公司 | 免疫抑制的治疗 |
| WO2022165313A1 (en) | 2021-02-01 | 2022-08-04 | Regenxbio Inc. | Gene therapy for neuronal ceroid lipofuscinoses |
| CN112831524B (zh) * | 2021-02-20 | 2023-06-13 | 苏州相奕生物技术有限公司 | 人工改造的重组腺病毒载体、由其包装的病毒及其应用 |
| CA3213066A1 (en) | 2021-03-29 | 2022-10-06 | Soo-Ok Kim | Recombinant chimeric adenoviral vector substituted by knob gene of chimpanzee adenovirus serotype 6, and application thereof |
| WO2022218997A1 (en) | 2021-04-12 | 2022-10-20 | Centre National De La Recherche Scientifique (Cnrs) | Novel universal vaccine presenting system |
| KR102874372B1 (ko) * | 2022-03-03 | 2025-10-23 | (주)진매트릭스 | 사스-코로나바이러스-2 감염증 예방용 재조합 발현 벡터 및 그 응용 |
| WO2023213764A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| US5240846A (en) | 1989-08-22 | 1993-08-31 | The Regents Of The University Of Michigan | Gene therapy vector for cystic fibrosis |
| US6174666B1 (en) | 1992-03-27 | 2001-01-16 | The United States Of America As Represented By The Department Of Health And Human Services | Method of eliminating inhibitory/instability regions from mRNA |
| WO1996012406A1 (en) | 1994-10-19 | 1996-05-02 | Genetic Therapy, Inc. | Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents |
| US5856152A (en) | 1994-10-28 | 1999-01-05 | The Trustees Of The University Of Pennsylvania | Hybrid adenovirus-AAV vector and methods of use therefor |
| DE69534166T2 (de) | 1994-10-28 | 2006-03-09 | Trustees Of The University Of Pennsylvania | Rekombinanter adenovirus und methoden zu dessen verwendung |
| US6127525A (en) | 1995-02-21 | 2000-10-03 | Cornell Research Foundation, Inc. | Chimeric adenoviral coat protein and methods of using same |
| US5770442A (en) * | 1995-02-21 | 1998-06-23 | Cornell Research Foundation, Inc. | Chimeric adenoviral fiber protein and methods of using same |
| US6019978A (en) * | 1995-06-05 | 2000-02-01 | The Wistar Institute Of Anatomy And Biology | Replication-defective adenovirus human type 5 recombinant as a vaccine carrier |
| US5698202A (en) * | 1995-06-05 | 1997-12-16 | The Wistar Institute Of Anatomy & Biology | Replication-defective adenovirus human type 5 recombinant as a rabies vaccine carrier |
| WO1998010087A1 (en) | 1996-09-06 | 1998-03-12 | Trustees Of The University Of Pennsylvania | Chimpanzee adenovirus vectors |
| EP0931158A1 (en) | 1996-09-06 | 1999-07-28 | The Trustees Of The University Of Pennsylvania | An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase |
| US5922315A (en) | 1997-01-24 | 1999-07-13 | Genetic Therapy, Inc. | Adenoviruses having altered hexon proteins |
| US5891994A (en) | 1997-07-11 | 1999-04-06 | Thymon L.L.C. | Methods and compositions for impairing multiplication of HIV-1 |
| WO1999014354A1 (en) | 1997-09-19 | 1999-03-25 | The Trustees Of The University Of The Pennsylvania | Methods and vector constructs useful for production of recombinant aav |
| EP1015619A1 (en) | 1997-09-19 | 2000-07-05 | The Trustees Of The University Of Pennsylvania | Methods and cell line useful for production of recombinant adeno-associated viruses |
| GB9720585D0 (en) | 1997-09-26 | 1997-11-26 | Smithkline Beecham Biolog | Vaccine |
| EP1064393B1 (en) | 1998-03-20 | 2004-12-29 | The Trustees Of The University Of Pennsylvania | Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| US20030017138A1 (en) * | 1998-07-08 | 2003-01-23 | Menzo Havenga | Chimeric adenoviruses |
| WO2000011140A1 (en) | 1998-08-20 | 2000-03-02 | The Wistar Institute Of Anatomy And Biology | Methods of augmenting mucosal immunity through systemic priming and mucosal boosting |
| US6258595B1 (en) | 1999-03-18 | 2001-07-10 | The Trustees Of The University Of Pennsylvania | Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| CA2378539A1 (en) | 1999-07-06 | 2001-01-11 | Merck & Co., Inc. | Adenovirus carrying gag gene hiv vaccine |
| BR0107972A (pt) | 2000-01-31 | 2002-11-05 | Smithkline Beecham Biologicals | Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano |
| AU2001234981A1 (en) | 2000-02-09 | 2001-08-20 | Genvec, Inc. | Adenoviral capsid containing chimeric protein ix |
| KR20040043129A (ko) * | 2001-06-22 | 2004-05-22 | 더 위스타 인스티튜트 오브 아나토미 앤드 바이올로지 | 세포독성 면역 반응을 유도하는 방법과 그에 유용한재조합체 원숭이 아데노바이러스 조성물 |
| EP1409748B1 (en) * | 2001-06-22 | 2011-10-26 | The Trustees of The University of Pennsylvania | Recombinant Adenoviruses comprising simian adenovirus proteins and uses thereof. |
| US20040136963A1 (en) | 2001-06-22 | 2004-07-15 | The Trustees Of The University Of Pennsylvania | Simian adenovirus vectors and methods of use |
| AU2002365366B2 (en) | 2001-11-21 | 2007-05-10 | The Trustees Of The University Of Pennsylvania | Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| AU2003285932A1 (en) | 2002-10-23 | 2004-05-13 | Glaxosmithkline Biologicals S.A. | Methods for vaccinating against malaria |
| CA2528511C (en) | 2003-06-20 | 2015-11-03 | The Trustees Of The University Of Pennsylvania | Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| US7291498B2 (en) | 2003-06-20 | 2007-11-06 | The Trustees Of The University Of Pennsylvania | Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| CA2563500C (en) * | 2004-04-28 | 2016-06-28 | The Trustees Of The University Of Pennsylvania | Immunization regimen with e4-deleted adenovirus prime and e1-deleted adenovirus boost |
| NZ550411A (en) * | 2004-04-28 | 2009-08-28 | Univ Pennsylvania | Polyvalent viral vectors and a system for production thereof |
| ES2361000T3 (es) * | 2004-04-28 | 2011-06-13 | The Trustees Of The University Of Pennsylvania | Suministro secuencial de moléculas inmunogénicas mediante administraciones de un adenovirus y de un virus adeno-asociado. |
| AR053275A1 (es) | 2005-05-12 | 2007-04-25 | Glaxo Group Ltd | Composicion de vacuna |
| EP2012822B1 (en) * | 2006-04-28 | 2010-01-20 | The Trustees of the University of Pennsylvania | Modified adenovirus hexon protein and uses thereof |
| US9364525B2 (en) | 2006-07-18 | 2016-06-14 | Glaxosmithkline Biologicals Sa | Vaccines for malaria |
| PL2137210T3 (pl) | 2007-03-02 | 2017-06-30 | Glaxosmithkline Biologicals Sa | Nowy sposób i kompozycje |
| EP2777185B1 (en) | 2011-10-13 | 2016-08-24 | Telefonaktiebolaget LM Ericsson (publ) | Method and node related to channel estimation |
-
2002
- 2002-11-20 AU AU2002365366A patent/AU2002365366B2/en not_active Ceased
- 2002-11-20 NZ NZ550416A patent/NZ550416A/en not_active IP Right Cessation
- 2002-11-20 IL IL16158402A patent/IL161584A0/xx unknown
- 2002-11-20 EP EP02803963.4A patent/EP1453543B1/en not_active Expired - Lifetime
- 2002-11-20 US US10/494,364 patent/US7247472B2/en not_active Expired - Fee Related
- 2002-11-20 SG SG200605559-4A patent/SG165153A1/en unknown
- 2002-11-20 KR KR1020047007792A patent/KR100987360B1/ko not_active Expired - Fee Related
- 2002-11-20 EP EP20100178483 patent/EP2286841A1/en not_active Withdrawn
- 2002-11-20 HU HU1300578A patent/HU230365B1/hu not_active IP Right Cessation
- 2002-11-20 JP JP2003547559A patent/JP2005511035A/ja not_active Withdrawn
- 2002-11-20 BR BR0214350-0A patent/BR0214350A/pt not_active Application Discontinuation
- 2002-11-20 WO PCT/US2002/033645 patent/WO2003046124A2/en not_active Ceased
- 2002-11-20 SG SG2013034475A patent/SG2013034475A/en unknown
- 2002-11-20 EP EP16181533.7A patent/EP3108899A1/en not_active Withdrawn
- 2002-11-20 HU HU0500987A patent/HU230364B1/hu not_active IP Right Cessation
- 2002-11-20 CN CN02823023XA patent/CN1578678B/zh not_active Expired - Fee Related
- 2002-11-20 CA CA2466431A patent/CA2466431C/en not_active Expired - Fee Related
- 2002-11-20 CA CA2990322A patent/CA2990322A1/en not_active Abandoned
- 2002-11-20 HU HU1400619A patent/HU230488B1/hu not_active IP Right Cessation
- 2002-11-20 MX MX2012000696A patent/MX351516B/es unknown
- 2002-11-20 NZ NZ532383A patent/NZ532383A/en not_active IP Right Cessation
- 2002-11-20 CA CA2852277A patent/CA2852277C/en not_active Expired - Fee Related
- 2002-11-20 EP EP10178464.3A patent/EP2301582B1/en not_active Expired - Lifetime
- 2002-11-20 NZ NZ564586A patent/NZ564586A/en not_active IP Right Cessation
- 2002-11-20 PL PL373602A patent/PL209133B1/pl unknown
- 2002-11-20 MX MXPA04004876A patent/MXPA04004876A/es active IP Right Grant
-
2004
- 2004-04-22 IL IL161584A patent/IL161584A/en active IP Right Grant
- 2004-04-23 ZA ZA2004/03117A patent/ZA200403117B/en unknown
- 2004-05-26 NO NO20042191A patent/NO332692B1/no not_active IP Right Cessation
- 2004-06-17 CO CO04056841A patent/CO5590973A2/es active IP Right Grant
-
2007
- 2007-06-19 US US11/820,439 patent/US8105574B2/en not_active Expired - Fee Related
-
2009
- 2009-01-29 JP JP2009018231A patent/JP5715749B2/ja not_active Expired - Fee Related
-
2010
- 2010-10-04 JP JP2010225018A patent/JP2011055835A/ja active Pending
-
2011
- 2011-12-27 US US13/337,608 patent/US8603459B2/en not_active Expired - Fee Related
-
2012
- 2012-03-21 NO NO20120337A patent/NO334512B1/no not_active IP Right Cessation
- 2012-11-29 IL IL223344A patent/IL223344A/en active IP Right Grant
-
2013
- 2013-04-30 NO NO20130590A patent/NO335438B1/no not_active IP Right Cessation
- 2013-08-09 JP JP2013167091A patent/JP2013252144A/ja active Pending
- 2013-11-07 US US14/073,979 patent/US9133483B2/en not_active Expired - Fee Related
-
2014
- 2014-01-02 IL IL230292A patent/IL230292A/en active IP Right Grant
- 2014-03-13 IL IL231502A patent/IL231502A/en not_active IP Right Cessation
- 2014-09-10 JP JP2014184006A patent/JP2015057052A/ja not_active Ceased
- 2014-09-10 JP JP2014184003A patent/JP2015057051A/ja not_active Withdrawn
-
2015
- 2015-08-12 US US14/824,336 patent/US20170119873A9/en not_active Abandoned
-
2016
- 2016-02-19 PH PH12016500338A patent/PH12016500338A1/en unknown
- 2016-11-11 JP JP2016220444A patent/JP2017035111A/ja active Pending
- 2016-11-11 JP JP2016220440A patent/JP2017035110A/ja active Pending
- 2016-11-11 JP JP2016220443A patent/JP2017070292A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015057052A5 (https=) | ||
| CN111108192B (zh) | 非人类人猿腺病毒核酸序列和氨基酸序列、含有其的载体及其用途 | |
| JP6970060B2 (ja) | アーフェンアデノウイルス（ゴリラ）又はアデノウイルスベクター、及び使用方法 | |
| JP6970647B2 (ja) | シミアン（ゴリラ）アデノウイルス又はアデノウイルスベクター、及び使用方法 | |
| JP6970059B2 (ja) | アーフェンアデノウイルス（ゴリラ）又はアデノウイルスベクター、及び使用方法 | |
| JP2018523980A5 (https=) | ||
| JP2014516536A5 (https=) | ||
| JP6277213B2 (ja) | サルアデノウイルスベクターの増殖方法 | |
| CN1124040A (zh) | 病毒载体和基因治疗应用 | |
| JP2012516679A5 (https=) | ||
| JP2020511940A5 (https=) | ||
| JP2017514483A5 (https=) | ||
| RU2013152648A (ru) | Аденовирус обезьян и гибридные аденовирусные векторы | |
| US11268108B2 (en) | Replication competent adenoviral vectors | |
| CN111479926A (zh) | 具有两个表达盒的猿猴腺病毒载体 | |
| CN111527213A (zh) | 具有两个编码rsv抗原蛋白或片段的表达盒的腺病毒载体 | |
| JP2009544303A5 (https=) | ||
| JP2009535031A5 (https=) | ||
| Borovjagin et al. | Adenovirus-based vectors for the development of prophylactic and therapeutic vaccines | |
| JP7240390B2 (ja) | 増強されたプロモーター | |
| WO2011066615A1 (en) | Methods and compositions for increasing titer of recombinant porcine adenovirus-3 vectors |